Helmink B, Reddy S, Gao J, Zhang S, Basar R, Thakur R, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549-555 pubmed publisher

Lu T, Chen Z, Cao Y, Ao L, Li Z, Gu X, et al. Dynamic immunogenicity after primary and booster inactivated SARS-CoV-2 vaccination in people living with HIV: A longitudinal observational study. J Med Virol. 2023;95:e28730 pubmed publisher

Zhang S, He J, Tang B, Zhou Q, Hu Y, Yu Y, et al. Cellular and Humoral Responses to Recombinant and Inactivated SARS-CoV-2 Vaccines in CKD Patients: An Observational Study. J Clin Med. 2023;12: pubmed publisher

Guo Q, Yang L, Peng R, Gao T, Chu X, Jiang D, et al. Safety and immunogenicity of inactivated COVID-19 vaccine in patients with metabolic syndrome: A cross-sectional observational study. Front Public Health. 2022;10:1067342 pubmed publisher

Zhao Y, He W, Wang C, Cui N, Yang C, You Z, et al. Characterization of intrahepatic B cells in acute-on-chronic liver failure. Front Immunol. 2022;13:1041176 pubmed publisher

Song R, Liu L, Pan Q, Liu J, Tan J, Deng J, et al. Short-term safety and immunogenicity of inactivated and peptide-based SARS-CoV-2 vaccines in patients with endocrine-related cancer. Front Immunol. 2022;13:1028246 pubmed publisher

Li H, Wang Y, Ao L, Ke M, Chen Z, Chen M, et al. Association between immunosuppressants and poor antibody responses to SARS-CoV-2 vaccines in patients with autoimmune liver diseases. Front Immunol. 2022;13:988004 pubmed publisher

Li T, Song R, Wang J, Zhang J, Cai H, He H, et al. Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancer. Int J Infect Dis. 2022;122:874-884 pubmed publisher

He T, Zhou Y, Xu P, Ling N, Chen M, Huang T, et al. Safety and antibody response to inactivated COVID-19 vaccine in patients with chronic hepatitis B virus infection. Liver Int. 2022;42:1287-1296 pubmed publisher

Torres Ruiz J, Pérez Fragoso A, Maravillas Montero J, Llorente L, Mejía Domínguez N, Páez Franco J, et al. Redefining COVID-19 Severity and Prognosis: The Role of Clinical and Immunobiotypes. Front Immunol. 2021;12:689966 pubmed publisher

Schultheiß C, Paschold L, Simnica D, Mohme M, Willscher E, von Wenserski L, et al. Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease. Immunity. 2020;53:442-455.e4 pubmed publisher